{"entity":{"type":"insider","cik":"0001753193","url":"/insider/0001753193","json_url":"/insider/0001753193.json","name":"WG Biotech ApS","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":10,"first":"2021-06-02","last":"2023-12-12","span_basis":"filed_date"},"name_variants":[{"name":"WG Biotech ApS","source":"filing","n_filings":10,"first_seen":"2021-06-02","last_seen":"2023-12-12"}],"transactions":[{"id":8729259,"accession":"0001104659-23-125200","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-125200","line_url":"/filing/0001104659-23-125200#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753193","owner_name":"WG Biotech ApS","owner_url":"/insider/0001753193","role":"Director","officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6455.0,"shares_display":"6,455","price_per_share":6.8523,"price_display":"6.85","price_state":"stated","total_value":44231.5965,"total_display":"44,231.60","shares_owned_after":4559233.0,"shares_owned_after_display":"4,559,233","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-11","filed_date":"2023-12-12","scope":"insider"},{"id":7891807,"accession":"0001104659-23-125055","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-23-125055","line_url":"/filing/0001104659-23-125055#line-3","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753193","owner_name":"WG Biotech ApS","owner_url":"/insider/0001753193","role":"Director","officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":102863.0,"shares_display":"102,863","price_per_share":7.0078,"price_display":"7.01","price_state":"stated","total_value":720843.3314,"total_display":"720,843.33","shares_owned_after":4552778.0,"shares_owned_after_display":"4,552,778","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-11","filed_date":"2023-12-11","scope":"insider"},{"id":7891804,"accession":"0001104659-23-125055","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-125055","line_url":"/filing/0001104659-23-125055#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753193","owner_name":"WG Biotech ApS","owner_url":"/insider/0001753193","role":"Director","officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18503.0,"shares_display":"18,503","price_per_share":6.9923,"price_display":"6.99","price_state":"stated","total_value":129378.5269,"total_display":"129,378.53","shares_owned_after":4449915.0,"shares_owned_after_display":"4,449,915","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-08","filed_date":"2023-12-11","scope":"insider"},{"id":7891801,"accession":"0001104659-23-125055","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-125055","line_url":"/filing/0001104659-23-125055#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753193","owner_name":"WG Biotech ApS","owner_url":"/insider/0001753193","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6183.0,"shares_display":"6,183","price_per_share":6.5,"price_display":"6.50","price_state":"stated","total_value":40189.5,"total_display":"40,189.50","shares_owned_after":4431412.0,"shares_owned_after_display":"4,431,412","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-07","filed_date":"2023-12-11","scope":"insider"},{"id":8473519,"accession":"0001104659-23-122898","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-122898","line_url":"/filing/0001104659-23-122898#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753193","owner_name":"WG Biotech ApS","owner_url":"/insider/0001753193","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":51837.0,"shares_display":"51,837","price_per_share":5.9702,"price_display":"5.97","price_state":"stated","total_value":309477.2574,"total_display":"309,477.26","shares_owned_after":4425229.0,"shares_owned_after_display":"4,425,229","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-29","filed_date":"2023-12-01","scope":"insider"},{"id":8203100,"accession":"0001104659-23-122092","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-122092","line_url":"/filing/0001104659-23-122092#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753193","owner_name":"WG Biotech ApS","owner_url":"/insider/0001753193","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30671.0,"shares_display":"30,671","price_per_share":5.8125,"price_display":"5.81","price_state":"stated","total_value":178275.1875,"total_display":"178,275.19","shares_owned_after":4373392.0,"shares_owned_after_display":"4,373,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-28","filed_date":"2023-11-29","scope":"insider"},{"id":8203096,"accession":"0001104659-23-122092","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-122092","line_url":"/filing/0001104659-23-122092#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753193","owner_name":"WG Biotech ApS","owner_url":"/insider/0001753193","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":62516.0,"shares_display":"62,516","price_per_share":5.4869,"price_display":"5.49","price_state":"stated","total_value":343019.0404,"total_display":"343,019.04","shares_owned_after":4342721.0,"shares_owned_after_display":"4,342,721","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-27","filed_date":"2023-11-29","scope":"insider"},{"id":7860496,"accession":"0001104659-23-061938","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-061938","line_url":"/filing/0001104659-23-061938#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753193","owner_name":"WG Biotech ApS","owner_url":"/insider/0001753193","role":"Director, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":101740.0,"shares_display":"101,740","price_per_share":9.6462,"price_display":"9.65","price_state":"stated","total_value":981404.388,"total_display":"981,404.39","shares_owned_after":4280205.0,"shares_owned_after_display":"4,280,205","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-15","filed_date":"2023-05-17","scope":"insider"},{"id":5536162,"accession":"0001104659-21-080237","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-080237","line_url":"/filing/0001104659-21-080237#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753193","owner_name":"WG Biotech ApS","owner_url":"/insider/0001753193","role":"Director, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11229.0,"shares_display":"11,229","price_per_share":36.1538,"price_display":"36.15","price_state":"stated","total_value":405971.0202,"total_display":"405,971.02","shares_owned_after":4178456.0,"shares_owned_after_display":"4,178,456","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-10","filed_date":"2021-06-11","scope":"insider"},{"id":5206353,"accession":"0001104659-21-079610","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-079610","line_url":"/filing/0001104659-21-079610#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753193","owner_name":"WG Biotech ApS","owner_url":"/insider/0001753193","role":"Director, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":116700.0,"shares_display":"116,700","price_per_share":36.1878,"price_display":"36.19","price_state":"stated","total_value":4223116.26,"total_display":"4,223,116.26","shares_owned_after":4189694.0,"shares_owned_after_display":"4,189,694","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-09","filed_date":"2021-06-10","scope":"insider"},{"id":5206350,"accession":"0001104659-21-079610","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-079610","line_url":"/filing/0001104659-21-079610#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753193","owner_name":"WG Biotech ApS","owner_url":"/insider/0001753193","role":"Director, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33300.0,"shares_display":"33,300","price_per_share":35.2761,"price_display":"35.28","price_state":"stated","total_value":1174694.13,"total_display":"1,174,694.13","shares_owned_after":4306394.0,"shares_owned_after_display":"4,306,394","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-08","filed_date":"2021-06-10","scope":"insider"},{"id":5096988,"accession":"0001104659-21-078952","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-078952","line_url":"/filing/0001104659-21-078952#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753193","owner_name":"WG Biotech ApS","owner_url":"/insider/0001753193","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":72400.0,"shares_display":"72,400","price_per_share":34.1517,"price_display":"34.15","price_state":"stated","total_value":2472583.08,"total_display":"2,472,583.08","shares_owned_after":4339694.0,"shares_owned_after_display":"4,339,694","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-07","filed_date":"2021-06-09","scope":"insider"},{"id":4281967,"accession":"0001104659-21-077702","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-077702","line_url":"/filing/0001104659-21-077702#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753193","owner_name":"WG Biotech ApS","owner_url":"/insider/0001753193","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3841.0,"shares_display":"3,841","price_per_share":34.0286,"price_display":"34.03","price_state":"stated","total_value":130703.8526,"total_display":"130,703.85","shares_owned_after":4412094.0,"shares_owned_after_display":"4,412,094","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-04","filed_date":"2021-06-07","scope":"insider"},{"id":4281964,"accession":"0001104659-21-077702","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-077702","line_url":"/filing/0001104659-21-077702#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753193","owner_name":"WG Biotech ApS","owner_url":"/insider/0001753193","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30666.0,"shares_display":"30,666","price_per_share":33.1856,"price_display":"33.19","price_state":"stated","total_value":1017669.6096,"total_display":"1,017,669.61","shares_owned_after":4415935.0,"shares_owned_after_display":"4,415,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-03","filed_date":"2021-06-07","scope":"insider"},{"id":5370318,"accession":"0001104659-21-075779","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-075779","line_url":"/filing/0001104659-21-075779#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753193","owner_name":"WG Biotech ApS","owner_url":"/insider/0001753193","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6864.0,"shares_display":"6,864","price_per_share":35.573,"price_display":"35.57","price_state":"stated","total_value":244173.072,"total_display":"244,173.07","shares_owned_after":4446601.0,"shares_owned_after_display":"4,446,601","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-02","scope":"insider"},{"id":5370314,"accession":"0001104659-21-075779","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-075779","line_url":"/filing/0001104659-21-075779#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001753193","owner_name":"WG Biotech ApS","owner_url":"/insider/0001753193","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":36.339,"price_display":"36.34","price_state":"stated","total_value":908475.0,"total_display":"908,475.00","shares_owned_after":4453465.0,"shares_owned_after_display":"4,453,465","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-28","filed_date":"2021-06-02","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001722964","name":"Y-mAbs Therapeutics, Inc.","url":"/issuer/0001722964","role":"Director, Ten percent owner, Other","n_filings":10,"first_seen":"2021-06-02","last_seen":"2023-12-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001753193","retrieved_at":"2026-08-20T23:46:23+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}